Login

FMR LLC 3 SEC Filings

Filed On Filing
29 Apr 2026 Form 3: Fmr Llc, 10% owner · Avalyn Pharma Inc
10 Mar 2026 Form 3: Fmr Llc, 10% owner · Rallybio Corp

Holds 211,798 shares of Common Stock

10 Apr 2025 Form 3: Fmr Llc, 10% owner · Beam Therapeutics Inc.

Holds 1,139,443 shares of Common Stock

30 Jan 2025 Form 3: Fmr Llc, 10% owner · Metsera, Inc.
12 Sep 2024 Form 3: Fmr Llc, 10% owner · Bicara Therapeutics Inc
13 Jun 2024 Form 3: Fmr Llc, 10% owner · Structure Therapeutics Inc

Holds 45,120 shares of Ordinary Shares

08 Apr 2024 Form 3: Fmr Llc, 10% owner · Sana Biotechnology Inc

Holds 4,832,423 shares of Common Stock

12 Oct 2023 Form 3: Fmr Llc, 10% owner · Structure Therapeutics Inc

Holds 61,527 shares of Ordinary Shares

14 Sep 2023 Form 3: Fmr Llc, 10% owner · Neumora Therapeutics Inc

Holds 1,911,729 shares of Common Stock

20 Jul 2023 Form 3: Fmr Llc, 10% owner · Turnstone Biologics Corp.
26 May 2023 Form 3: Fmr Llc, 10% owner · Fidelity Multi-Strategy Credit Fund

Holds 2,500,000 shares of Common Shares of Beneficial Ownership

23 Mar 2023 Form 3: Fmr Llc, 10% owner · Fidelity Private Credit Fund

Holds 1,280,001.754 shares of Class I Common Shares of Beneficial Interest

02 Feb 2023 Form 3: Fmr Llc, 10% owner · Structure Therapeutics Inc
19 Oct 2022 Form 3: Fmr Llc, 10% owner · Prime Medicine Inc
24 Jan 2022 Form 3: Fmr Llc, 10% owner · Beam Therapeutics Inc.

Holds 3,914,014 shares of Common Stock

28 Dec 2021 Form 3: Fmr Llc, 10% owner · Verve Therapeutics, Inc.

Holds 1,037,294 shares of Common Stock

21 Oct 2021 Form 3: Fmr Llc, 10% owner · Xilio Therapeutics Inc

Holds 26,315 shares of Common Stock

04 Oct 2021 Form 3: Fmr Llc, 10% owner · Toast Inc
29 Jul 2021 Form 3: Fmr Llc, 10% owner · Rallybio Corp
22 Jul 2021 Form 3: Fmr Llc, 10% owner · Caribou Biosciences, Inc.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support